Influence of continuation of beta blockers during dobutamine stress echocardiography for the assessment of myocardial viability in patients with severe ischemic left ventricular dysfunction

被引:7
|
作者
Poldermans, D
Sozzi, FB
Bax, JJ
Boersma, E
Duncker, DJ
Vourvouri, E
Elhendy, A
Valkema, R
Roelandt, JRTC
机构
[1] Erasmus Med Ctr Rotterdam, Dept Cardiol, Rotterdam, Netherlands
[2] Erasmus Med Ctr Rotterdam, Dept Nucl Med, Rotterdam, Netherlands
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2001年 / 88卷 / 01期
关键词
D O I
10.1016/S0002-9149(01)01591-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:68 / 70
页数:3
相关论文
共 50 条
  • [1] The influence of continuing beta-blockers during dobutamine stress echocardiography for the assessment of myocardial viability in patients with ischemic left ventricular dysfunction
    Poldermans, D
    Sozzi, F
    Bax, JJ
    Boersma, E
    Valkema, R
    Sutter, J
    Duncker, DJ
    't Veld, AJMI
    Vourvouri, E
    Roelandt, JR
    CIRCULATION, 2000, 102 (18) : 576 - 576
  • [2] The influence of continuing beta-blockers during dobutamine stress echocardiography for the assessment of myocardial viability in patients with ischaemic left ventricular dysfunction
    Poldermans, D
    Sozzi, F
    Bax, JJ
    Boersma, E
    Valkema, R
    Roelandt, JRTC
    EUROPEAN HEART JOURNAL, 2000, 21 : 577 - 577
  • [3] Assessment of myocardial viability with dobutamine stress echocardiography in patients with ischemic left ventricular dysfunction
    Yao, SS
    Chaudhry, FA
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2005, 22 (01): : 71 - 83
  • [4] Prognostic implication of myocardial viability during dobutamine stress echocardiography in diabetic and nondiabetic patients with chronic ischemic left ventricular dysfunction
    Cortigiani, L.
    Sicari, R.
    Desideri, A.
    Bigi, R.
    Borges, A.
    Palagi, C.
    Bovenzi, F.
    Picano, E.
    EUROPEAN HEART JOURNAL, 2006, 27 : 531 - 531
  • [5] Dobutamine stress echocardiography for the detection of myocardial viability in patients with left ventricular dysfunction taking β blockers:: accuracy and optimal dose
    Zaglavara, T
    Haaverstad, R
    Cumberledge, B
    Irvine, T
    Karvounis, H
    Parharidis, G
    Louridas, G
    Kenny, A
    HEART, 2002, 87 (04) : 329 - 335
  • [6] Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction
    Afridi, I
    Grayburn, PA
    Panza, JA
    Oh, JK
    Zoghbi, WA
    Marwick, TH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (04) : 921 - 926
  • [7] Assessment of myocardial viability by dobutamine stress echocardiography in patients with ischemic heart disease
    Gornyakova, NB
    Botvin, IM
    Sumarokov, AB
    Afanasyeva, YB
    Naumov, VG
    KARDIOLOGIYA, 2004, 44 (07) : 29 - 34
  • [8] DELINEATION OF MYOCARDIAL VIABILITY WITH LOW-DOSE DOBUTAMINE STRESS-ECHOCARDIOGRAPHY IN PATIENTS WITH CHRONIC ISCHEMIC LEFT-VENTRICULAR DYSFUNCTION
    VANOVERSCHELD, JL
    MARWICK, T
    DHONDT, AM
    BAUDHUIN, T
    WIJNS, W
    MELIN, JA
    CIRCULATION, 1993, 88 (04) : 111 - 111
  • [9] SAFETY OF DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN PATIENTS WITH SEVERE LEFT-VENTRICULAR DYSFUNCTION
    SINGH, K
    TAUKE, JT
    BONOW, RO
    CHAUDHRY, FA
    CLINICAL RESEARCH, 1994, 42 (03): : A358 - A358
  • [10] SAFETY OF DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN PATIENTS WITH CHRONIC ISCHEMIC LEFT-VENTRICULAR DYSFUNCTION
    HEPNER, AM
    BACH, DS
    DEEB, GM
    BOLLING, SF
    BRUNSTING, LA
    SHAYNA, V
    STAFFORD, K
    SCHWAIGER, M
    ARMSTRONG, WF
    CIRCULATION, 1993, 88 (04) : 404 - 404